| Filed On | Filing |
|---|---|
| 29 Jan 2026 |
Form 3: Kovalyov George, Director
Holds 0 shares of Common Stock |
| 01 Feb 2024 |
Form 3: Braeden Lichti, 10% owner
Holds 1,967,965 shares of Common Stock |
| 25 Jan 2024 |
Form 3: Beuchler Brenda, CMO
Holds 56,226 shares of Common Stock |
| 18 Jan 2024 |
Form 3: Plews Jordan R., Director
Holds 2,993,120 shares of Common Stock |
| 18 Jan 2024 |
Form 3: Jp Bio Consulting Llc, Director
Holds 2,851,454 shares of Common Stock |
| 18 Jan 2024 |
Form 3: Muilenburg Crystal, Director
Holds 20,000 shares of Common Stock |
| 18 Jan 2024 |
Form 3: Kraneiss Chris, CMO
Holds 31,250 shares of Common Stock |
| 17 Jan 2024 |
Form 3: Daley Juliana, Director
Holds 1,200 shares of Common Stock |
| 17 Jan 2024 |
Form 3: Parry Jeffrey, Director
Holds 41,667 shares of Common Stock |
| 17 Jan 2024 |
Form 3: Abou-Sayed Hatem, Director
Holds 1,513,571 shares of Common Stock |
| 17 Jan 2024 |
Form 3: Hatem Abou-Sayed Md Mba FACS, a Professional Medical Corp, Director
Holds 1,371,905 shares of Common Stock |
| 17 Jan 2024 |
Form 3: Bensler Graydon, Director
Holds 983,120 shares of Common Stock |
| 17 Jan 2024 |
Form 3: Gb Capital Ltd., Director
Holds 841,454 shares of Common Stock |
| 17 Jan 2024 |
Form 3: Bwl Investments Ltd., 10% owner
Holds 3,623,965 shares of Common Stock |
Loading...